747. Emerging Infections at the Human-Domestic Animal Interface
Session: Symposium: One World, One Health, One Medicine
Friday, October 21, 2011: 3:15 PM
Room: 153ABC
In this global community, humans travel and animals are moved making the risk of disease translocation global as well. Although we have many wildlife sources of rabies, the canine rabies virus variant is extinct in the USA. The recent translocation of dogs from Puerto Rico, Thailand, India, and Iraq, which developed rabies from their origin, demonstrates the risk of disease re-introduction. This risk can be mitigated through carefully crafted requirements. Like many zoonosis, rabies prevention requires the cooperation of animal control, natural resource personnel, veterinarians, diagnosticians, public health professionals, physicians, and others.  Although rabies excites the imagination, there are vulnerabilities.  As the reality of a global community is realized with rapid and high volume exchange of animate beings and inanimate products, diligent attention and dedicated effort will be required to maintain and indeed, even advance emerging and zoonotic disease control, with rabies as a tangible “best-practices” template, beyond the major advances made in the last 50 yrs.


Cathleen A. Hanlon, DVM, PhD, Rabies Laboratory, Kansas State University College of Veterinary Medicine, Manhattan, KS

Dr Hanlon is the director of the Kansas State University Rabies Laboratory. This Laboratory provides primary diagnosis for Kansas and Nebraska and serves as a regional reference laboratory. It is one of the highest volume rabies serology centers in the world handling over 70,000 human and animal samples annually. We meet quality monitoring standards of the Clinical Laboratory Improvement Amendments and numerous state departments of health and routinely communicate with export authorities throughout the world. The laboratory participates in proficiency testing for animal serology tests for export, by the Fluorescent Antibody Virus Neutralization (FAVN) test and the Rapid Fluorescent Focus Inhibition Test (RFFIT), as well as diagnostic proficiency testing. From 1996 through 2007, Dr Hanlon served as the Veterinary Medical Officer of the Rabies Team at CDC and prior to that was part of Rabies Research Unit of the Wistar Institute and Thomas Jefferson University in PA. Dr Hanlonís experience occurs at the intersection of human and animal and health where she diligently practices the overarching principles of One Health through state, national and international leadership in human and animal disease surveillance, control and policy development. These experiences include WHO/PAHO invited consultancies and a 90-day assignment to the World Organization for Animal Health (OIE) while at CDC. Recently, she served as a key leader of the World Rabies Day initiative. Dr. Hanlon has published over 70 peer reviewed articles, 8 textbook chapters and delivered over 150 scientific presentations. Dr Hanlon achieved her veterinary medical degree in 1987 at the University of Pennsylvania, School of Veterinary Medicine and her PhD in 1994 Comparative Medicine, as part of the Biomedical Research Group at the University of Pennsylvania. She was board-certified in Veterinary Preventive Medicine in 2005.



Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.